2 completed, 1 active not recruiting, 1 terminated. 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Terminated 1 |
| Phase 3 | 1 | Completed 1 |
Follow Cirrhosis, Cryptogenic: new trials by email Literature Review of Cirrhosis, Cryptogenic trials Research Report on Cirrhosis, Cryptogenic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Liver Cirrhosis Network Cohort Study Cirrhosis, Cirrhosis, Liver | Active not recruiting | Northwestern University | 1222 | 2022-11-18 | 2026-01-13 | |
| Clinical Study In Infants With Rapidly Progressive Lysosomal Acid Lipase Deficiency Sebelipase Alfa - Lysosomal Acid Lipase Deficiency | Phase 2 | Terminated | Alexion Pharmaceuticals, Inc. | 10 | 2014-06-06 | 2019-11-18 |
| Bartonella in Liver Transplant Patients skin punch biopsy collection, Blood collection, Urine sample collection - Cryptogenic Cirrhosis, Cryptogenic Chronic Hepatitis | Completed | University of Minnesota | 3 | 2013-12-01 | 2022-03-02 | |
| Safety, Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of Sebelipase Alfa in Children With Growth Failure Due to Lysosomal Acid Lipase Deficiency Sebelipase alfa (SBC-102) - Lysosomal Acid Lipase Deficiency, Wolman Disease | Phase 2 / Phase 3 | Completed | Alexion Pharmaceuticals, Inc. | 9 | 2011-05-04 | 2019-01-30 |
Non-alcoholic Fatty Liver Disease (3) · Chanarin-Dorfman Syndrome (2) · Cholesterol Ester Storage Disease (2) · Liver Diseases, Alcoholic (2) · Niemann-Pick Diseases (2) · Wolman Disease (2) · Bartonella Infections (1) · Fibrosis (1) · Hepatitis, Autoimmune (1) · Hepatitis, Chronic (1) · Liver Cirrhosis (1) · Liver Cirrhosis, Alcoholic (1) · Liver Cirrhosis, Biliary (1)
Digestive System Diseases (4) · Liver Diseases (4) · Alcohol-Induced Disorders (3) · Alcohol-Related Disorders (3) · Chemically-Induced Disorders (3) · Fatty Liver (3) · Substance-Related Disorders (3) · Brain Diseases (2) · Brain Diseases, Metabolic (2) · Brain Diseases, Metabolic, Inborn (2) · Central Nervous System Diseases (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Genetic Diseases, Inborn (2) · Hemic and Lymphatic Diseases (2) · Hepatitis (2)
Sebelipase alfa (2) · Blood Specimen Collection (1)
Alexion Pharmaceuticals, Inc. (2) · Northwestern University (1) · University of Minnesota (1)
United States (4) · United Kingdom (2) · Egypt (1) · Finland (1) · France (1) · Ireland (1) · Italy (1)
Abigail Smith (1) · Marna E Ericson, phd (1)
U01DK130113 (1), U01DK130134 (1), U01DK130168 (1), U01DK130177 (1), U01DK130180 (1), U01DK130181 (1), U01DK130185 (1), U01DK130190 (1), U01DK130197 (1), U01DK130221 (1), U24DK130164 (1)